Background Triple negative breast cancer (TNBC) is one of the most biologically aggressive
breast cancers and lacks effective treatment options, resulting in a poor prognosis …

In this study, we aimed to evaluate the anticancer effect of benzimidazole derivatives on
triple-negative breast cancer (TNBC) and investigate its underlying mechanism of action …

Evodiamine (Evo) is a quinazolinocarboline alkaloid found in Evodia rutaecarpa and
exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping …

Background Triple negative breast cancer (TNBC) is a specific subtype of breast cancer with
a poor prognosis due to its aggressive biological behaviour and lack of therapeutic targets …

Sophoraflavanone G (SG), a prenylated flavonoid extracted from Sophora flavescens, has
been found to possess antitumor activity in several types of human cancer. However, the …

Exosomes are lipid bilayer extracellular vesicles with a size of 30–150 nm, which can be
released by various types of cells including breast cancer cells. Exosomes are enriched with …

Triple-negative breast cancer (TNBC) is characterized by its highly heterogeneous
microenvironment and propensity for aggressive behavior, both of which represent, along …

Objective Triple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor
prognosis that seriously threatens women's health. There is still a lack of effective …

Unlike other breast cancer subtypes, triple-negative breast cancer (TNBC) has no specific
targets and is characterized as one of the most aggressive subtypes of breast cancer that …

Triple-negative breast cancer (TNBC) has become a serious threat to women's health.
Research on epigenetic drugs is gradually deepening and is expected to provide new …